Your browser doesn't support javascript.
loading
The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL.
Akpinar, Seval; Dogu, Mehmet Hilmi; Celik, Serhat; Ekinci, Omer; Hindilerden, Ipek Yonal; Dal, Mehmet Sinan; Davulcu, Eren Arslan; Tekinalp, Atakan; Hindilerden, Fehmi; Ozcan, Busra Gokce; Hacibekiroglu, Tuba; Erkurt, Mehmet Ali; Bagci, Metin; Namdaroglu, Sinem; Korkmaz, Gulten; Bilgir, Oktay; Cagliyan, Gulsum Akgun; Ozturk, Hacer Berna Afacan; Serin, Istemi; Tiryaki, Tarik Onur; Ozatli, Duzgun; Korkmaz, Serdal; Ulas, Turgay; Eser, Bulent; Turgut, Burhan; Altuntas, Fevzi.
Afiliação
  • Akpinar S; Department of Internal Medicine, Division of Hematology, Tekirdag Namik Kemal University Medical School, Tekirdag, Turkey. Electronic address: seakpinar@nku.edu.tr.
  • Dogu MH; Liv Hospital Ulus, Department of Hematology, Istinye University, Istanbul, Turkey.
  • Celik S; Department of Hematology, Erciyes University, Kayseri, Turkey.
  • Ekinci O; Department of Hematology, University of Health Sciences, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey.
  • Hindilerden IY; Istanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul University, Istanbul, Turkey.
  • Dal MS; Department of Hematology & Apheresis Unit, University of Health Sciences, Ankara Oncology Training and Research Hospital, Ankara, Turkey.
  • Davulcu EA; Department of Hematology, University of Health Sciences, Bakirkoy Dr Sadi Konuk Training and Research Hospital, Istanbul, Turkey.
  • Tekinalp A; Meram Faculty of Medicine, Department of Hematology, Necmettin Erbakan University, Konya, Turkey.
  • Hindilerden F; Department of Hematology, University of Health Sciences, Bakirkoy Dr Sadi Konuk Training and Research Hospital, Istanbul, Turkey.
  • Ozcan BG; Department of Internal Medicine, Celal Bayar University, Manisa, Turkey.
  • Hacibekiroglu T; Department of Hematology, Sakarya University, Sakarya, Turkey.
  • Erkurt MA; Department of Hematology, Inonu University, Malatya, Turkey.
  • Bagci M; Department of Hematology, Selcuk University, Konya, Turkey.
  • Namdaroglu S; Department of Hematology, University of Health Sciences, Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.
  • Korkmaz G; Department of Hematology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.
  • Bilgir O; Department of Hematology, University of Health Sciences, Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.
  • Cagliyan GA; Department of Hematology, Pamukkale University, Denizli, Turkey.
  • Ozturk HBA; Department of Hematology, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.
  • Serin I; Department of Hematology, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, Turkey.
  • Tiryaki TO; Istanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul University, Istanbul, Turkey.
  • Ozatli D; Department of Hematology, Ondokuz Mayis University, Samsun, Turkey.
  • Korkmaz S; Department of Hematology & Apheresis Unit, University of Health Sciences, Kayseri City Training and Research Hospital, Kayseri, Turkey.
  • Ulas T; School of Medicine, Department of Internal Medicine, Division of Hematology, Near East University, Nicosia, Cyprus.
  • Eser B; Department of Hematology, Medical Park Antalya Hospital, Antalya, Turkey.
  • Turgut B; Department of Internal Medicine, Division of Hematology, Tekirdag Namik Kemal University Medical School, Tekirdag, Turkey.
  • Altuntas F; Department of Hematology & Apheresis Unit, University of Health Sciences, Ankara Oncology Training and Research Hospital, Ankara, Turkey; School of Medicine, Department of Internal Medicine, Division of Hematology, Ankara Yildirim Beyazit University, Ankara, Turkey.
Clin Lymphoma Myeloma Leuk ; 22(3): 169-173, 2022 03.
Article em En | MEDLINE | ID: mdl-34629286
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article